Primary Hyperoxaluria Type 1 Clinical Trial
The aim of this study is to know the difference between protein profiles (multi-analyte
profile) of PH1 patients, idiopathic hypercalciuria (IH) patients and PH1 patients
'siblings. Idiopathic hypercalciuria is a less severe kidney disease that PH1, which also
leads to the formation of kidney stones.
The aim is to identify patterns of discriminating markers associated with primary
hyperoxaluria type 1 (PH1) that will significantly improve clinical diagnosis and prognosis.
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Terminated |
NCT02795325 -
A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
|
Phase 1 | |
| Completed |
NCT03067142 -
Proteomics of Primary Hyperoxaluria Type 1
|
||
| Active, not recruiting |
NCT04152200 -
A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1
|
Phase 3 | |
| Recruiting |
NCT05001269 -
Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function
|
Phase 2 | |
| Recruiting |
NCT04982393 -
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
|
||
| Not yet recruiting |
NCT06465472 -
Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3
|
Phase 3 | |
| Recruiting |
NCT04580420 -
Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD
|
Phase 2 |